MISTY NEWTON: Open Payments
NPI 1033517321 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,808 in 85 payments from 10 companies in 2025. Trend: 2023 $2,274 · 2024 $2,107 · 2025 $2,808
Food & beverage: $2,772Education: $36
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $476 |
| Teva Pharmaceuticals USA, Inc. | 13 | $425 |
| Janssen Pharmaceuticals, Inc | 12 | $375 |
| ABBVIE INC. | 11 | $344 |
| Alkermes, Inc. | 6 | $305 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $246 |
| Amgen Inc. | 11 | $209 |
| Vanda Pharmaceuticals Inc. | 2 | $208 |
| E.R. Squibb & Sons, L.L.C. | 8 | $149 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
Products named: VRAYLAR, UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA, CAPLYTA, FANAPT, ARISTADA, ENBREL.
Industry payments across PA — which companies pay providers there.
